Novel multisensor probe for monitoring bladder temperature during locoregional chemohyperthermia for nonmuscle-invasive bladder cancer: Technical feasibility study

Journal of Endourology

Volumn 27, Issue 12, 2013, Pages 1504-1509

  Cordeiro, Ernesto R ^a   Geijsen, Debby E ^b   Zum Vörde Sive Vörding, Paul J ^b   Schooneveldt, Gerben ^b   Sijbrands, Jan ^b   Hulshof, Maarten C ^b   De La Rosette, Jean ^a   De Reijke, Theo M ^a   Crezee, Hans ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOPSY; BLADDER CAPACITY; BLADDER WALL; CHEMOHYPERTHERMIA; CHEMOTHERAPY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEASIBILITY STUDY; HUMAN; HYPERTHERMIA; MULTISENSOR PROBE BLADDER TEMPERATURE MONITOR; NON MUSCLE INVASIVE BLADDER CANCER; NONHUMAN; OUTCOME ASSESSMENT; PORCINE MODEL; PRIORITY JOURNAL; RADIOLOGY PHANTOM; TEMPERATURE MEASUREMENT; THERMOMETRY;

ADMINISTRATION, INTRAVESICAL; ANTIBIOTICS, ANTINEOPLASTIC; BODY TEMPERATURE; EQUIPMENT DESIGN; FEASIBILITY STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MITOMYCIN; MONITORING, PHYSIOLOGIC; NEOPLASM INVASIVENESS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84890496405     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2013.0179     Document Type: Article

References (23)

1. Anastasiadis A, Cordeiro E, Bus MT, et al. Follow-up procedures for non-muscle-invasive bladder cancer: An update. Expert Rev Anticancer Ther 2012;12:1229-1241.
2. Babjuk M, Oosterlinck W, Sylvester R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 2011;59:997-1008.
3. Anastasiadis A, de Reijke TM. Best practice in the treatment of nonmuscle invasive bladder cancer. Ther Adv Urol 2012; 4:13-32.
4. Roupret M, Neuzillet Y, Larre S, et al. [Guidelines for good practice of intravesical instillations of BCG and mitomycin C from the French national cancer committee (CC-AFU) for non-muscle-invasive bladder cancer]. (Fre) Prog Urol 2012; 22:920-931.
5. Sylvester RJ, Brausi MA, Kirkels WJ, et al. Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guerin, and bacillus Calmette- Guerin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder. Eur Urol 2010;57:766-773.
6. Alfred Witjes J, Hendricksen K, Gofrit O, et al. Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: Experience of the European Synergo working party. World J Urol 2009;27:319-324.
7. Colombo R, Da Pozzo LF, Lev A, et al. Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer. J Urol 1996;155:1227-1232.
8. Colombo R, Da Pozzo LF, Salonia A, et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 2003;21:4270-4276.
9. Lammers RJ, Witjes JA, Inman BA, et al. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: A systematic review. Eur Urol 2011;60: 81-93.
10. Colombo R, Brausi M, Da Pozzo L, et al. Thermochemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication. A pilot study on marker lesion. Eur Urol 2001;39: 95-100.
11. van der Heijden AG, Kiemeney LA, Gofrit ON, et al. Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder. Eur Urol 2004;46:65-72.
12. Crezee J, Van Haaren PM, Westendorp H, et al. Improving locoregional hyperthermia delivery using the 3-D controlled AMC-8 phased array hyperthermia system: A preclinical study. Int J Hyperthermia 2009;25: 581-592.
13. Rigatti P, Lev A, Colombo R. Combined intravesical chemotherapy with mitomycin C and local bladder microwave- induced hyperthermia as a preoperative therapy for superficial bladder tumors. A preliminary clinical study. Eur Urol 1991;20:204-210.
14. Gofrit ON, Shapiro A, Pode D, et al. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology 2004;63:466-471.
15. Moskovitz B, Meyer G, Kravtzov A, et al. Thermochemotherapy for intermediate or high-risk recurrent superficial bladder cancer patients. Ann Oncol 2005;16: 585-589.
16. Nativ O, Witjes JA, Hendricksen K, et al. Combined thermochemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin. J Urol 2009;182:1313-1317.
17. Halachmi S, Moskovitz B, Maffezzini M, et al. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder. Urol Oncol 2011;29:259-264.
18. Colombo R, Salonia A, Leib Z, et al. Pavone-Macaluso M, Engelstein D. Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscleinvasive bladder cancer (NMIBC). BJU Int 2011;107: 912-918.
19. van der Zee J, Peer-Valstar JN, Rietveld PJ, et al. Practical limitations of interstitial thermometry during deep hyperthermia. Int J Radiat Oncol Biol Phys 1998;40:1205- 1212.
20. van der Zee J, Gonzalez D, van Rhoon GC, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355:1119-1125.
21. Das SK, Clegg ST, Samulski TV. Computational techniques for fast hyperthermia temperature optimization. Med Phys 1999;26:319-328.
22. Wiersma J, van Maarseveen RA, Van Dijk JD. A flexible optimization tool for hyperthermia treatments with RF phased array systems. Int J Hyperthermia 2002;18: 73-85.
23. Kok HP, Van Haaren PM, van de Kamer JB, et al. Highresolution temperature-based optimization for hyperthermia treatment planning. Phys Med Biol 2005;50: 3127-3141.